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INTRODUCTION
TGF-β family members regulate a variety of
cellular functions and play important roles in cell
differentiation, adhesion, migration, and apoptosis
(1). This superfamily consists of a large group of
growth and differentiation factors, including TGF-
βs, activins, inhibins, nodal, bone morphogenetic
proteins (BMPs) and other related proteins (2 -5).
Activins signal through types I and II transmem-
brane serine/threonine kinase receptors (6), and
bind to type II receptors independently (7). Upon
ligand binding, type I receptors are recruited to
type II receptors and produce activated receptor
complexes. Activated type I receptors phospho-
rylate Smad proteins, which regulates the tran-
scription of various genes in the nucleus (2, 8).
One of the type I receptors, ALK7, was initially
cloned from rats as an orphan receptor (9 -11). The
ligand of this orphan receptor was recently identi-
fied as nodal, activin B and activin AB (12, 13).
ALK7 mRNA was anatomically distributed in the
central nervous system and the periphery (9 -11).
ALK7 is expressed not only in the neuron system,
but also in insulin-producing islet β cells and white
and brown adipose tissues (10, 11, 14) ; however,
the specific function of ALK7 in adipose tissue is
not known. Recent studies in adiposcience re-
vealed that adipocytes play active roles in many
physiologic and pathologic processes. In order to
confirm whether ALK7 is involved in adipogene-
sis, we analyzed the expression of ALK7 during
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adipocyte differentiation using a preadipocyte cell
line, 3T3 -L1 and mouse primary cells of adipose
tissue-derived SVF.
MATERIALS AND METHODS
Adipocyte cell culture
We used a preadipocyte cell line, 3T3 -L1 and
mouse primary culture of SVF cells. 3T3 -L1 pread-
ipocytes were maintained in Dulbecco’s modified
Eagle’s medium (DMEM) with 10% calf serum,
supplemented with penicillin and streptomycin (P/S)
at 37 under humidified 5% CO2 atmosphere. To
prepare SVF cells, inguinal and visceral adipose
tissues were excited from mice, and digested with
3.33 mg/ml type II collagenase with gentle rocking
in Hanks’ Balanced Salt Solution for 60 min at 37.
After sequential filtration through 100 and 40 µm
filters, the isolated SVF cells were suspended in
fetal bovine serum (FBS), and cultured in DMEM
with 10% FBS and P/S. Only SVF cells without
passaging were used in this study.
After preadipocyte cells reached confluence, dif-
ferentiation was induced by culturing cells in in-
duction medium supplemented with adipogenic
agents (0.5 mM 3-isobutyl-1-methylxanthine, 1 µM
dexamethasone, and 10 µg/ml insulin in DMEM
containing 10% FBS). Two days later, the induc-
tion medium was replaced by the maintenance
medium (DMEM containing 10% FBS and P/S),
and the medium was renewed every two days.
RT-PCR
Total RNA was extracted from cells using Trizol
reagent (Invitrogen) according to the manufac-
turer’s protocol. Total RNA was dissolved in di-
ethyl pyrocarbonate-treated water and the concen-
tration of RNA was determined by absorbance at
260 nm. We analyzed the expression of ALK7,
other activin receptors and adipogenic markers
including CCAAT/enhancer binding protein α (C
/EBPα), C/EBPβ, adipocyte fatty acid-binding
protein (aP2) and peroxisome proliferator-activated
receptor γ (PPARγ) by RT-PCR. Single-strand cDNA
was synthesized using a SuperScript First-Strand
Synthesis System (Invitrogen) according to the
manufacturer’s protocol. PCR was conducted using
MyCycler Thermal Cycler (BIO-RAD). In the case
of ALK7, 5% dimethyl sulfoxide (DMSO) was
added to the reaction mixture to improve PCR am-
plification.
The primer sets used in this study are shown in
Table 1. Most of those primers were described pre-
viously (15). PCR conditions were optimized for
detection within a linear range. For the amplifica-
tion of ALK7, PCR was performed as follows : an
initial denaturing step of 94 for 2 min, followed
by 40 cycles of 94 for 1 min, 60 for 1 min, and
72 for 1 min. All other genes were amplified by
the following programs including ‘stepdown’ steps:
10 initial cycles of 30 sec denaturation at 94, 15
sec annealing at 74-54, 30 sec elongation at 72
where the annealing temperature was decreased
by 4 per 2 cycles, followed by 28 cycles of 30 sec
denaturation at 94, 15 sec annealing at 54, 30
sec elongation at 72, and a final extension step
at 72 for 10 min. To amplify C/EBPα in SVF
cells, the first 10 initial stepdown cycles were fol-
lowed by 30 cycles of 30 sec denaturation at 94,
15 sec annealing at 54, 30 sec elongation at 72,
and a final extension step at 72 for 10 min. To
Table 1. Sequences of the primer sets used for PCR
Primers Forward Reverse GenBank accessionnumber
mActRI 5’-ATGACTACCTTCAGCTCACT-3’ 5’-CTTCGCCAGAGAAGTTAATG-3’ BC058718
mActRIB 5’-ACCGCTACACAGTGACCATT-3’ 5’-TCTTCACATCTTCCTGCACG-3’ NM007395
mActRII 5’-CTTAAGGCTAATGTGGTCTC-3’ 5’-GACTAGATTCTTTGGGAGGA-3’ M65287
mActRIIB 5’-ATCGTCATCGGAAACCTCCC-3’ 5’-CAGCCAGTGATCCTTAATC-3’ M84120
mC/EBPα 5’-AGTCGGCCGACTTCTACGAG-3’ 5’-GATGTAGGCGCTGATGT-3’ M62362
mC/EBPβ 5’-GCAAGAGCCGCGACAAG-3’ 5’-GGCTCGGGCAGCTGCTT-3’ X62600
mPPARγ 5’-AGGCCGAGAAGGAGAAGCTGTTG-3’ 5’-TGGCCACCTCTTTGCTCTGCTC-3’ U01664
maP2 5’-TCTCACCTGGAAGACAGCTCCTCCTCG-3’ 5’-TTCCATCCAGGCCTCTTCCTTTGGCTC-3’ K02109
mALK7 5’-GGCTGTGAAAATATTCTCCTCC-3’ 5’-GGATCTGAAGGCACCATGTCAT-3’ AY127050
m18S 5’-GGGAGCCTGAGAAACGGC-3’ 5’-CCGCTCCCAAGATCCAACTAC-3’ X00686
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amplify C/EBPβ and PPARγ in 3T3-L1, the first 10
initial stepdown cycles were followed by 25 cycles
of the same amplification as C/EBPα in SVF cells.
To amplify aP2 and 18S, similar PCR reactions were
performed with 23 and 21 cycles of amplification in
3T3-L1 and SVF cells, respectively. PCR products
were separated on 2% agarose gel and visualized
with ethidium bromide.
Western blotting and immunofluorescence
Cells were harvested and lysed in 50 mM Tris-
HCl (pH 7.5), 1% NP-40, 150 mMNaCl, 1% aprotinin
and 1 mM PMSF by sonication. Protein concentra-
tions of cell lysates were determined using BioRad
Protein assay kit. 10 µg of protein was subjected to
12% SDS-PAGE and transferred to Immobilon-P
membrane (Millipore, MA, USA). After blocking
with 5% skim milk in PBS, the membrane was in-
cubated with the primary antibody, rabbit anti-
ALK7 (13) (diluted 1 : 500), followed by incubation
with the secondary antibody conjugated to horse-
radish peroxidase, anti-rabbit IgG (Amersham Bi-
osciences ; diluted 1 : 2500) for 3 hours. ALK7 was
detected by chemiluminescence with the ECL
Western blotting detection system (Amersham Bi-
osciences).
Oil Red O staining was performed to visualize
oil droplets in the differentiated cells. Cells were
washed once with PBS, fixed with 3.7% formalde-
hyde in PBS, and incubated in 0.3% Oil Red O
solution to visualize oil droplets. We also used
Sudan III to investigate oil drops when the cells
were analyzed by immunofluorescence at the
same time. For co-imaging of Sudan III fluores-
cence and ALK7 immunofluorescence, cells were
fixed for 30 min in 2% paraformaldehyde at room
temperature, permeabilized with 0.1% Triton X-
100, and blocked with 1.5% BSA prior to incuba-
tion with polyclonal rabbit anti-ALK7 antibody
(diluted at 1 : 100). FITC-labeled anti-rabbit IgG
was used as the secondary antibody.
RESULTS
ALK7 expression during adipocyte differentiation
As a model system for adipogenesis, we used
the 3T3-L1 preadipocyte cell line. On reaching
confluence, 3T3 -L1 preadipocytes were growth ar-
rested by contact inhibition. These growth-
arrested cells reentered the cell cycle after hormo-
nal induction, proliferation arrested again, and
finally underwent terminal adipocyte differentia-
tion over several days. Under these conditions, we
investigated ALK7 expression with known adipo-
genic markers by RT-PCR. Transcription of the C/
EBPβ gene has been shown to be expressed
shortly after exposure of the cells to differentiation
inducers (16). C/EBPβ in turn transactivates the
expression of C/EBPα and PPARγ genes, the two
transcription factors responsible for establishing
and maintaining the adipocyte phenotype. PPARγ
is a major regulator of terminal adipocyte differen-
tiation and drives the expression of several
adipocyte-specific genes, such as the fatty acid
binding protein, aP2 (17).
In our experiment, 3T3 -L1 cells started to ex-
press C/EBPβ mRNA immediately after induction
(day 1), as shown in Fig.1A. The expressions of
PPARγ and aP2 were detected from day 2. Under
these conditions, all activin receptors except ALK7
were expressed constantly before and after adipo-
cyte differentiation in 3T3 -L1 cells (Fig. 1B). In con-
trast, ALK7 was not expressed in 3T3-L1 preadipo-
cytes but was significantly induced in the late
phase of adipocyte differentiation (day 4 -day 6), as
shown in Fig.1B.
In order to confirm the expression of ALK7, we
next tested the expression of ALK7 by Western
blotting. We prepared cell extracts from samples
from day 4 to day 8 after adipogenic induction, and
performed Western blotting with the anti-ALK7
antibody. Distinct 55kDa bands corresponding to
ALK7 protein were detected weakly from day 4.
On days 6 and 8, the expression of ALK7 protein
gradually increased (Fig. 2).
We further analyzed the expression of ALK7 by
immunofluorescence during adipogenesis and im-
munostained 3T3-L1 cells with anti-ALK7 antibody
from day 4 after adipogenic induction. Oil droplets
were visualized by Sudan III staining. On day 4, the
expression of ALK7 was easily detected (Fig. 3).
As expected, cells that expressed ALK7 at a high
level accumulated oil droplets, indicating that they
were differentiated into mature adipocytes. In con-
trast, no accumulation of oil droplets was observed
in ALK7-negative cells.
In order to detect endogenous ALK7 expressed on
the cell surface, we performed similar immunostain-
ing without the permeabilization of plasma mem-
branes with Triton X-100. As shown in Fig. 4, cells
expressing ALK7 on the cell surface accumulated
oil droplets on day 4. On day 6 after induction, we ob-
served a remarkable increase of oil droplets com-
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A.
B.
Fig. 1. Gene expressions during the differentiation of 3T3-L1 cells.
(A) Expressions of adipogenic markers.
After 3T3-L1 preadipocytes reached confluence (day 0), differentiation was induced by treating the cells with the adipogenic me-
dium. Two days later (day 2), the medium was replaced by the maintenance medium and cultured as previously described in MA-
TERIALS AND METHODS. Total RNA was isolated on the indicated days after the induction of differentiation. The specific primers
listed on Table 1 were used for RT-PCR analyses.
(B) Expressions of activin receptors.
Total RNA preparation and RT-PCR assays were performed as described in Fig. 1A.
Fig. 2. Expression of ALK7 protein during 3T3-L1 adipocyte differentiation. Western blotting analysis was performed using anti-
ALK7 antibody and the protein band was detected by enhanced chemiluminescence (ECL).
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pared to on day 4 (data not shown). In particular,
large oil droplets were detected on day 6, and ALK7
was expressed on those cells. These data sug-
gested that signaling through ALK7 expressed on
the cell surface may be involved in the late phase
of adipocyte maturation.
ALK7 expression during primary adipocyte differentiation
In order to further confirm the involvement of
ALK7 in adipogenesis, we used a mouse primary
culture of SVF cells. SVF cells have also been par-
ticularly useful for validating results obtained from
preadipose cell lines such as 3T3-L1 (18) and they
represent the physiological system compared with
3T3-L1 cells. To evaluate whether these fibroblast-
like cells can differentiate into mature adipocytes,
we examined their differentiation using Oil Red O
staining. As shown in Fig. 5, SVF cells cultured in
the adipogenic medium showed a remarkable in-
crease of oil droplets in contrast to the control
cells. Oil droplets appeared after 3 or 4 days of in-
duction with dynamic morphological changes of
the cell shape. Fibroblast-like cells differentiated
into round-shaped cells, which is characteristic of
oil droplet accumulation. On the other hand, we
did not observe spontaneous cell differentiation
without treatment with the induction medium.
We examined the expression of activin recep-
tors by RT-PCR during adipocyte differentiation.
Fig. 4. Immunostaining of ALK7 expressed on the cell sur-
face on day 4 after adipogenic induction. Cells were treated as
in Fig. 3 except that permeabilization with Triton X-100 was omit-
ted. The localization of ALK7 (green) was detected by anti-ALK7
antibody and FITC-conjugated secondary antibody. Oil drops
and nuclei were detected with Sudan III (red) and DAPI
(blue), respectively. The scale bar represents 30 µm.
Fig. 3. Immunostaining of ALK7 in 3T3-L1 cells. The cells were treated with the maintenance medium (A) or the induction me-
dium (B) for 2 days. After culturing the cells for 2 days in the maintenance medium, the cells were fixed with 2% paraformaldehyde,
and ALK7 protein was probed with a polyclonal anti-ALK7 followed by FITC-conjugated secondary antibody (green). Oil drops were
detected with Sudan III staining (red). The nuclei were stained with DAPI (blue). The scale bar represents 30 µm.
Fig. 5. Oil red O staining of SVF cells. The cells were treated
with the maintenance medium (A) or the induction medium
(B). Following 2 days’ induction, the cells were cultured for 4
days in the maintenance medium, fixed with 3.7% formalde-
hyde, and stained with 0.3% Oil Red O solution. Representative
photomicrographs (magnification, ×200) are shown. The scale
bar represents 30 µm.
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We prepared RNA from SVF cells on day 0 to day
5 after adipocyte induction. As is the case with 3T3 -L1
cells, ALK7 was induced in the late phase of
adipocyte differentiation in SVF cells, whereas the
expression levels of all activin receptors except
ALK7 were not changed during adipogenesis (Fig. 6
A,B). These results confirmed that ALK7 is a
marker specifically expressed in the late phase of
adipocyte differentiation.
A.
B.
Fig. 6. Gene expressions during the differentiation of SVF cells.
(A) Expressions of adipogenic markers.
Total RNA preparation and RT-PCR assay were performed as described in Fig. 1A. Lane M denotes the DNA size marker, 100bp DNA
ladder (Promega).
(B) Expressions of activin receptors.
Total RNA preparation and RT-PCR assay were performed as described in Fig. 1A.
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DISCUSSION
Obesity is a nutritional disorder most wide-
spread in humans. It serves as a significant risk
factor for many diseases such as diabetes, cancer,
heart disease, and hypertension (19, 20). Increased
adipose tissue mass can result from the multiplica-
tion of new fat cells through adipogenesis and/or
from increased deposition of cytoplasmic triglyc-
erides in fat cells (21). To study the process of adi-
pocyte differentiation, 3T3 -L1 preadipocyte cells
have been widely used as an in vitro model system.
TGF-β superfamily members have been shown
to regulate the differentiation of a variety of cell types,
including adipocytes (22, 23). For example, TGF-β
inhibits adipocyte differentiation through Smad2-
and Smad3-dependent pathways (24). Smad pro-
teins interact with C/EBPβ and decrease gene ex-
pression of PPARγ. Myostatin, a TGF-β family mem-
ber, is a potent negative regulator of skeletal mus-
cle growth. Myostatin binds ActRIIB and ALK4 or
ALK5, and activates a TGF-β-like signaling path-
way via Smad2 and Smad3(25). Myostatin also
inhibits preadipocyte differentiation in 3T3-L1 cells,
which is mediated, in part, by the altered regula-
tion of C/EBPα and PPARγ (26). Recently, activin
A has been shown to inhibit adipogenesis in the
early phase via Smad3-mediated impairment of the
transactivation function of C/EBP (15).
In this study, we found that ALK7 is specifically
induced during the late phase of adipogenesis,
although all the other activin receptors are ex-
pressed constantly in both 3T3-L1 and SVF cells.
The specific expression of ALK7 on the cell sur-
face of oil droplet-accumulating cells suggests that
ALK7 may function in those cells. Recently,
ligands for ALK7 were identified as nodal, activin
B and activin AB (12, 13). ALK7 is highly ex-
pressed not only in the nervous system, but also in
adult pancreatic islets, duodenum, prostate, fetal
testis and ovary, where activins play significant
roles (27). The recent finding that activin B can
augment glucose-dependent insulin secretion in
the mouse pancreatic β cell line (13) raises the
possibility that ALK7-dependent activin B signal-
ing may be involved in the regulation of adipo-
genesis ; however, further study will be necessary
to clarify the specific functions of ALK7 in adipo-
cytes.
In summary, we found that ALK7 is induced in
the later phase of adipocyte differentiation in 3T3-
L1 cells and SVF cells. ALK7 could be a useful
marker for the analysis of adipogenesis.
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